Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

News & Events

Featured

News

Goodwin Guides Sail Biomedicines in Strategic Collaboration to Advance In Vivo CAR-T Medicines

Goodwin Advises Dwelly on Raising $170 Million Series B

Goodwin Advises Royalty Pharma on Acquiring Royalty Interest in AstraZeneca’s cliramitug for Up To $425 Million From Neurimmune

Goodwin Advises P-1 AI on Its $50 Million Series A Financing

Events

ChIPs Global Summit 2026

Goodwin Pharma Services Symposium

Real Estate Technology Leadership Forum

Goodwin Connects with Clients and Industry Leaders at the 2026 Farnborough International Air Show

Media Contact